START NOW: a cognitive behavioral skills training for adolescent girls with conduct or oppositional defiant disorder ? a randomized clinical trial / Christine M. FREITAG ; Arne POPMA ; Lucres NAUTA-JANSEN ; Kerstin KONRAD ; Eva UNTERNAEHRER ; Katharina ACKERMANN ; Anka BERNHARD ; Anne MARTINELLI ; Helena OLDENHOF ; Malou GUNDLACH ; Gregor KOHLS ; Martin PRÄTZLICH ; Meinhard KIESER ; Ronald LIMPRECHT ; Nora M. RASCHLE ; Noortje VRIENDS ; Robert L. TRESTMAN ; Marietta KIRCHNER ; Linda KERSTEN in Journal of Child Psychology and Psychiatry, 65-3 (March 2023)  

Public ISBD [article]  inJournal of Child Psychology and Psychiatry > 65-3 (March 2023) . - p.316-327 Titre : START NOW: a cognitive behavioral skills training for adolescent girls with conduct or oppositional defiant disorder ? a randomized clinical trial Type de document : Texte imprimé et/ou numérique Auteurs : Christine M. FREITAG, Auteur ; Arne POPMA, Auteur ; Lucres NAUTA-JANSEN, Auteur ; Kerstin KONRAD, Auteur ; Eva UNTERNAEHRER, Auteur ; Katharina ACKERMANN, Auteur ; Anka BERNHARD, Auteur ; Anne MARTINELLI, Auteur ; Helena OLDENHOF, Auteur ; Malou GUNDLACH, Auteur ; Gregor KOHLS, Auteur ; Martin PRÄTZLICH, Auteur ; Meinhard KIESER, Auteur ; Ronald LIMPRECHT, Auteur ; Nora M. RASCHLE, Auteur ; Noortje VRIENDS, Auteur ; Robert L. TRESTMAN, Auteur ; Marietta KIRCHNER, Auteur ; Linda KERSTEN, Auteur Article en page(s) : p.316-327 Index. décimale : PER Périodiques Résumé : Background Conduct disorder (CD) and oppositional defiant disorder (ODD) both convey a high risk for maladjustment later in life and are understudied in girls. Here, we aimed at confirming the efficacy of START NOW, a cognitive-behavioral, dialectical behavior therapy-oriented skills training program aiming to enhance emotion regulation skills, interpersonal and psychosocial adjustment, adapted for female adolescents with CD or ODD. Methods A total of 127 girls were included in this prospective, cluster randomized, multi-center, parallel group, quasi-randomized, controlled phase III trial, which tested the efficacy of START NOW (n?=?72) compared with standard care (treatment as usual, TAU, n?=?55). All female adolescents had a clinical diagnosis of CD or ODD, were 15.6 (+1.5) years on average (range: 12?20?years), and were institutionalized in youth welfare institutions. The two primary endpoints were the change in number of CD/ODD symptoms between (1) baseline (T1) and post-treatment (T3), and (2) between T1 and 12-week follow-up (T4). Results Both treatment groups showed reduced CD/ODD symptoms at T3 compared with T1 (95% CI: START NOW?=??4.87, ?2.49; TAU?=??4.94, ?2.30). There was no significant mean difference in CD/ODD symptom reduction from T1 to T3 between START NOW and TAU (?0.056; 95% CI?=??1.860, 1.749; Hedge's g?=??0.011). However, the START NOW group showed greater mean symptom reduction from T1 to T4 (?2.326; 95% CI?=??4.274, ?0.378; Hedge's g?=??0.563). Additionally, secondary endpoint results revealed a reduction in staff reported aggression and parent-reported irritability at post assessment. Conclusions Although START NOW did not result in greater symptom reduction from baseline to post-treatment compared with TAU, the START NOW group showed greater symptom reduction from baseline to follow-up with a medium effect size, which indicates a clinically meaningful delayed treatment effect. En ligne : https://doi.org/10.1111/jcpp.13896 Permalink : https://www.cra-rhone-alpes.org/cid/opac_css/index.php?lvl=notice_display&id=520 [article] START NOW: a cognitive behavioral skills training for adolescent girls with conduct or oppositional defiant disorder ? a randomized clinical trial [Texte imprimé et/ou numérique] / Christine M. FREITAG, Auteur ; Arne POPMA, Auteur ; Lucres NAUTA-JANSEN, Auteur ; Kerstin KONRAD, Auteur ; Eva UNTERNAEHRER, Auteur ; Katharina ACKERMANN, Auteur ; Anka BERNHARD, Auteur ; Anne MARTINELLI, Auteur ; Helena OLDENHOF, Auteur ; Malou GUNDLACH, Auteur ; Gregor KOHLS, Auteur ; Martin PRÄTZLICH, Auteur ; Meinhard KIESER, Auteur ; Ronald LIMPRECHT, Auteur ; Nora M. RASCHLE, Auteur ; Noortje VRIENDS, Auteur ; Robert L. TRESTMAN, Auteur ; Marietta KIRCHNER, Auteur ; Linda KERSTEN, Auteur . - p.316-327. in Journal of Child Psychology and Psychiatry > 65-3 (March 2023) . - p.316-327 Index. décimale : PER Périodiques Résumé : Background Conduct disorder (CD) and oppositional defiant disorder (ODD) both convey a high risk for maladjustment later in life and are understudied in girls. Here, we aimed at confirming the efficacy of START NOW, a cognitive-behavioral, dialectical behavior therapy-oriented skills training program aiming to enhance emotion regulation skills, interpersonal and psychosocial adjustment, adapted for female adolescents with CD or ODD. Methods A total of 127 girls were included in this prospective, cluster randomized, multi-center, parallel group, quasi-randomized, controlled phase III trial, which tested the efficacy of START NOW (n?=?72) compared with standard care (treatment as usual, TAU, n?=?55). All female adolescents had a clinical diagnosis of CD or ODD, were 15.6 (+1.5) years on average (range: 12?20?years), and were institutionalized in youth welfare institutions. The two primary endpoints were the change in number of CD/ODD symptoms between (1) baseline (T1) and post-treatment (T3), and (2) between T1 and 12-week follow-up (T4). Results Both treatment groups showed reduced CD/ODD symptoms at T3 compared with T1 (95% CI: START NOW?=??4.87, ?2.49; TAU?=??4.94, ?2.30). There was no significant mean difference in CD/ODD symptom reduction from T1 to T3 between START NOW and TAU (?0.056; 95% CI?=??1.860, 1.749; Hedge's g?=??0.011). However, the START NOW group showed greater mean symptom reduction from T1 to T4 (?2.326; 95% CI?=??4.274, ?0.378; Hedge's g?=??0.563). Additionally, secondary endpoint results revealed a reduction in staff reported aggression and parent-reported irritability at post assessment. Conclusions Although START NOW did not result in greater symptom reduction from baseline to post-treatment compared with TAU, the START NOW group showed greater symptom reduction from baseline to follow-up with a medium effect size, which indicates a clinically meaningful delayed treatment effect. En ligne : https://doi.org/10.1111/jcpp.13896 Permalink : https://www.cra-rhone-alpes.org/cid/opac_css/index.php?lvl=notice_display&id=520

---

1 (1 - 1 / 1)